Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant
3 clinical trials · Condition
◉ Watch Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant
| Record | Firm | Date |
|---|---|---|
| Pharmacogenetic and Pharmacokinetics of Naproxen and Associated Naproxen-esomeprazole (NCT03092193) | University of Sao Paulo | 2017-03-01 |
| Pharmacogenetic Testing Among Home Health Patients (NCT02378220) | Genelex Corporation | 2015-03-01 |
| YouScript IMPACT Registry (NCT02191358) | Genelex Corporation | 2014-10-01 |
Track Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant automatically
Every clearance here is in the API, with alerts when new ones post.